StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.73+0.02 (+0.05%)

Close on Nov 18, 2026Market cap $27.98BP/E –Yield –

Roivant Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Roivant Sciences's total debt was $12.00M at Jun 30, 2024. For fiscal 2023 it was $12.00M, down 70.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Mar 31, 2024$12.00M-70.5%
FY2022Mar 31, 2023$40.72M-80.6%
FY2021Mar 31, 2022$210.03M+23.3%
FY2020Mar 31, 2021$170.28M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2024CQ2 2024Jun 30, 2024$12.00M-73.0%
Q4 FY2023CQ1 2024Mar 31, 2024$12.00M-70.5%
Q3 FY2023CQ4 2023Dec 31, 2023$45.71M+21.2%
Q2 FY2023CQ3 2023Sep 30, 2023$49.00M+37.0%
Q1 FY2023CQ2 2023Jun 30, 2023$44.41M+33.3%
Q4 FY2022CQ1 2023Mar 31, 2023$40.72M-80.6%
Q3 FY2022CQ4 2022Dec 31, 2022$37.72M-81.5%
Q2 FY2022CQ3 2022Sep 30, 2022$35.75M-82.1%
Q1 FY2022CQ2 2022Jun 30, 2022$33.30M-82.1%
Q4 FY2021CQ1 2022Mar 31, 2022$210.03M+23.3%
Q3 FY2021CQ4 2021Dec 31, 2021$204.04M–
Q2 FY2021CQ3 2021Sep 30, 2021$199.87M–
Q1 FY2021CQ2 2021Jun 30, 2021$186.35M–
Q4 FY2020CQ1 2021Mar 31, 2021$170.28M–

More Roivant Sciences figures

See a number that looks wrong?